Clinical trial Recruiting at 1 site Interventional Ages 18 to 65 Women only

Personalized digital healthcare for managing side effects in breast cancer survivors

Official title: Development and Validation of Personalized Digital Healthcare Technology and Service Model for the Management and Recovery of Side Effects of Treatment in Breast Cancer Survivors

Run by Samsung Medical Center · NCT06729684 · Data updated 2026-11-12

This study is testing a new digital health program to help breast cancer survivors manage side effects from their treatments using a mobile app and smartwatch.

More Breast Cancer trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexWomen only
Enrollment72 (estimated)
SponsorSamsung Medical Center
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Seoul, Republic of Korea)
StatusRecruiting
StartedNovember 13, 2024
Main results expectedMay 31, 2025
Study endsMay 31, 2025
Registry record updatedDecember 11, 2024
Trial IDNCT06729684 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 18 to 65 who have undergone surgery for Stage 1-2 breast cancer and possess a smartphone.

Probably not a fit

Patients who have only undergone mastectomy without additional treatments or those with severe comorbidities that hinder participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to develop and validate a personalized digital healthcare model designed to help breast cancer survivors manage acute and chronic side effects resulting from various treatments such as surgery, chemotherapy, and radiation. The approach involves utilizing digital health technologies, including a mobile application and smartwatch, to provide tailored self-management strategies based on individual self-assessment results. The study will also evaluate the clinical applicability of this model to address the diverse healthcare needs of breast cancer survivors effectively.

Why it matters

Potential benefit: If successful, this model could significantly improve the quality of life for breast cancer survivors by providing personalized support for managing treatment-related side effects.

How similar studies have gone: While the approach of using digital health technologies for managing side effects in cancer survivors is gaining traction, this specific model is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals who have undergone surgery for Stage 1-2 breast cancer
* Individuals who have had a unilateral mastectomy
* Aged 18 years or older and under 65 years
* Possessing a smartphone with either an Android or iOS operating system
* Individuals who voluntarily decide to participate after receiving detailed information about the study and provide written consent

Exclusion Criteria:

* Individuals who have undergone mastectomy only and are not receiving chemotherapy, radiation, or hormone therapy
* Individuals with severe comorbidities (such as underlying diseases, neuromuscular disorders, cognitive or mental impairments, visual disabilities, etc.) that make it difficult to use the application or participate in the exercise intervention

Discontinuation Criteria

* Individuals who undergo delayed breast reconstruction surgery during the study period
* Individuals who develop severe complications or experience cancer metastasis or recurrence in other organs during the study period, leading to a change in treatment
* Occurrence of a major illness unrelated to study participation
* Failure to comply with the instructions of the study physician
* Situations where the participant voluntarily withdraws from the study or becomes unable to continue participating

Where it's running

  • Samsung Medical Center
    Seoul, Republic of Korea, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.